Arkolith/Insider Trading/PCSA/Form 4

Bigora Sian

Chief Development OfficerProcessa Pharmaceuticals, Inc. (PCSA) · full profile →Form 4 · filed Apr 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2025Tax withholding(F)3K$0.41$1K34K
Apr 1, 2025Option exercise(M)15K——37K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000897069-25-000789) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML